This webinar was recorded live on June 7, 2023.
It is available on demand through June 30, 2024.
Register above for access.
Description
The COVID-19 pandemic created a need for rapid, point-of-care testing that was unparalleled in modern times. Within a few months, healthcare centers were closing doors to patients, patients were not comfortable seeking healthcare, and COVID-19 was spreading through communities — all due to the lack of rapid and local testing. As healthcare providers look to the post-pandemic future, there is a need to reflect on how the pandemic impacted health systems in general and point-of-care testing in particular.
During this webinar, point-of-care directors from three different institutions will share their perspectives on how the pandemic changed the need for and use of point-of-care testing. This will be followed by a panel discussion on key elements of each institution’s response. The webinar will cover how the pandemic changed the role of the laboratory in test development and implementation, one institution’s experience in moving from very high volume centralized testing to low volume and point-of-care testing to support rapid testing needs, and issues related to test utilization as point of care testing is deployed.
Target Audience
This activity is designed for physicians, lab supervisors, lab directors (and/or assistant directors), lab managers (supervisory and/or non-supervisory), medical technologists, point-of-care coordinators, pathologists, institutional leaders, and other laboratory professionals overseeing/conducting within this topic.
Learning Objectives
After attending this session, participants will be able to:
- List ways in which the COVID-19 pandemic changed the role of laboratories and point-of-care testing programs in test development and implementation
- Describe the process of moving from high volume, centralized testing to lower volume and point of care solutions and challenges associated with this transition
- Define strategies to ensure appropriate test utilization as tests move from central lab to point-of-care environments
Faculty
Moderator
Leslie J. Donato, PhD, DABCC
Laboratory Director
Mayo Clinic
Rochester, MN
Speakers
Brad S Karon MD PhD FADLM FCAP
Professor of Laboratory Medicine and Pathology
Chair, Division of Clinical Core Laboratory Services
Co-director, Point of Care Testing
Mayo Clinic
Rochester, MN
Omai Garner, PhD, D(ABMM)
Associate Professor
UCLA Department of Pathology and Laboratory Medicine
Los Angeles, CA
Alagarraju (KUMAR) Muthukumar, PhD, DABCC
Associate Professor, Department of Pathology, UT Southwestern Medical Center
Medical Director, Clinical Chemistry, Clements University Hospital, UTSW
CLIA Director, Clinical Chemistry, UT Southwestern Clinics and outreach areas
Dallas, TX
DISCLOSURES AND STATEMENT OF INDEPENDENCE
The Association for Diagnostics & Laboratory Medicine (formerly AACC) is dedicated to ensuring balance, independence, objectivity, and scientific rigor in all educational activities. All participating planning committee members and faculty are required to disclose to the program audience any financial relationships related to the subject matter of this program. Disclosure information is reviewed in advance in order to manage and resolve any possible conflicts of interest. The intent of this disclosure is to provide participants with information on which they can make their own judgments.
The following faculty reported financial relationships:
- Alagarraju (KUMAR) Muthukumar, PhD, DABCC
- Grant/Research Support: Abbott Diagnostics, Google Verily, Regeneron, Roche, Fluxergy and BlueJay Diagnostics
The following faculty reported no relevant financial relationship:
- Leslie J. Donato, PhD, DABCC
- Omai Garner, PhD, D(ABMM)
- Brad S Karon MD PhD FADLM FCAP
CONTENT VALIDITY
All recommendations involving clinical medicine are based on evidence accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients; AND/OR all scientific research referred to or reported in support or justification of a patient care recommendation conforms to generally accepted standards of experimental design, data collection, and analysis.
ACCREDITATION STATEMENT
This activity is approved for 1.0 ACCENT® continuing education credits. Activity ID# 4221. This activity was planned in accordance with ACCENT® Standards and Policies.
SUCCESSFUL COMPLETION STATEMENT
Verification of Participation certificates are provided to registered participants based on completion of the activity, in its entirety, and the activity evaluation. For questions regarding continuing education, please email [email protected].